Tiziana Life Sciences Appoints Ivor Elrifi as New Chief Executive Officer. Ivor has extensive experience in advising clients on strategic transactional work and regularly counsels’ clients with respect to investments, business development and mergers and acquisitions, including acquisition transactions involving Novartis, Eli Lilly, Biogen and Astellas. Welcome to the team Ivor! $TLSA #foralumab #MS #Alzheimers #SPMS #ALS https://lnkd.in/emr6v235
Tiziana Life Sciences’ Post
More Relevant Posts
-
Interesting insights and learnings from Theresa. Learn more about people and culture 👍
What can we learn from successful mergers and acquisitions? 💡 In the latest Chemistry Today panel discussion, our colleague Theresa Ledbetter Ledbetter from Evonik Health Care reflects on the strategic acquisition of Tippecanoe Laboratories from Eli Lilly, which marked a significant step in our journey to become a leader in the contract development and manufacturing business. 🌐 The full story 👉 https://ow.ly/VOBC50SflNc #Evonik #healthcare #CDMO #CMO #drugsubstance #paneldiscussion
To view or add a comment, sign in
-
Seale & Associates, Inc. is pleased to announce the release of the May 2024 edition of our Mergers and Acquisitions (M&A) report for the U.S. This report is an all-inclusive guide that provides details on the transactions carried out by American companies in May. May saw a significant shift in the mergers and acquisitions market in the U.S. A total of 1,144 transactions were announced within the country, a 2.0% increase compared to the same period last year. However, 145 transactions were carried out abroad, indicating an 11.6% decrease from the previous year. The report features notable companies such as Biogen, HI-Bio, AGS Health, and Mariana Oncology, showing the market's continued potential. If you want to receive this exclusive monthly report or any of our industry reports, kindly subscribe at https://lnkd.in/gExMnuBz. Stay ahead of the competition with our detailed analysis and insights. #MergersAndAcquisitions #BusinessReports #MarketTrends #USMarket #FinanceInsights #IndustryAnalysis #SealeAndAssociates #FinancialReports #CorporateTransactions #USCompanies
To view or add a comment, sign in
-
Seale & Associates, Inc. is pleased to announce the release of the May 2024 edition of our Mergers and Acquisitions (M&A) report for the U.S. This report is an all-inclusive guide that provides details on the transactions carried out by American companies in May. May saw a significant shift in the mergers and acquisitions market in the U.S. A total of 1,144 transactions were announced within the country, a 2.0% increase compared to the same period last year. However, 145 transactions were carried out abroad, indicating an 11.6% decrease from the previous year. The report features notable companies such as Biogen, HI-Bio, AGS Health, and Mariana Oncology, showing the market's continued potential. If you want to receive this exclusive monthly report or any of our industry reports, kindly subscribe at https://lnkd.in/gExMnuBz. Stay ahead of the competition with our detailed analysis and insights. #MergersAndAcquisitions #BusinessReports #MarketTrends #USMarket #IndustryAnalysis #SealeAndAssociates #FinancialReports #CorporateTransactions #USCompanies
To view or add a comment, sign in
-
The first quarter of 2024 witnessed mergers and acquisitions positively shaping the industry's trajectory. These deals reflect the current trend in Big Pharma: snapping up small late-stage biotechs. In parallel, the IPO market showcased more promise, underscoring the industry's resilience and investors' confidence in innovative biotech ventures. Read more in Fierce Biotech: https://bit.ly/3Ja42Si #MergersAndAcquisitions #PharmaceuticalIndustry #Innovation #Healthcare #IPOs
To view or add a comment, sign in
-
Seale & Associates, Inc. is pleased to announce the release of the May 2024 edition of our Mergers and Acquisitions (M&A) report for the U.S. This report is an all-inclusive guide that provides details on the transactions carried out by American companies in May. May saw a significant shift in the mergers and acquisitions market in the U.S. A total of 1,144 transactions were announced within the country, a 2.0% increase compared to the same period last year. However, 145 transactions were carried out abroad, indicating an 11.6% decrease from the previous year. The report features notable companies such as Biogen, HI-Bio, AGS Health, and Mariana Oncology, showing the market's continued potential. If you want to receive this exclusive monthly report or any of our industry reports, kindly subscribe at https://lnkd.in/gExMnuBz. Stay ahead of the competition with our detailed analysis and insights. #MergersAndAcquisitions #BusinessReports #MarketTrends #USMarket #FinanceInsights #IndustryAnalysis #SealeAndAssociates #FinancialReports #CorporateTransactions #USCompanies
To view or add a comment, sign in
-
Many of today’s most lucrative medicines might not have become so without mergers and acquisitions. And while 2021 and 2022 were much quieter for dealmaking, there are signs of a rebound. Check out this database from BioPharma Dive, which is tracking the latest M&A activity, and dates back to 2018: https://hubs.la/Q02mQfF40 #M&A #Biopharma
Biotech M&A is on the upswing. Track the latest deals here.
To view or add a comment, sign in
-
𝗜𝘁’𝘀 𝗴𝗼𝗼𝗱 𝘁𝗼 𝗯𝗲 𝗯𝗮𝗰𝗸 𝗮𝘁 IESE Business School (𝗷𝘂𝘀𝘁 𝗳𝗼𝗿 𝗮 𝗰𝗼𝘂𝗽𝗹𝗲 𝗼𝗳 𝗱𝗮𝘆𝘀. 😊) Happy to be back! Even though it’s only for a moment this time. Couple of productive days with my colleague Prof. Vardit Landsman, working on (1) the commercial consequences of mergers and acquisitions and (2) measuring launch excellence in pharma. #Team #LaunchExcellence #Pharma #Academia #IESE #IESEBusinessSchool, Julian Villanueva Galobart, Carlos Garcia-Pont, Jorge Gonzalez
To view or add a comment, sign in
-
5 Strategies to Expand Your Pharma Company 1. Research and Development (R&D) Investment 2. Market Diversification 3. Strategic Partnerships 4. Mergers and Acquisitions (M&A) 5. Digital Transformation The pharma industry is competitive, expensive, and constantly evolving, requiring leaders to embrace multiple approaches to form a well-rounded expansion plan. The key to making your expansion plan successful is analyzing trends, building a solid internal team and tailoring each strategy to fit the unique needs of your pharma company. #pharma #strategic_partnership #market_diversification #licensing https://lnkd.in/duKz2Fij
To view or add a comment, sign in
-
Pharma and life sciences are witnessing increased collaboration and partnership deals to address strategic gaps and foster innovation Read the full article: 2024 Outlook for Pharma Mergers and Acquisitions ▸ https://lttr.ai/ANCXs #mergers #acquistions #jpm2024 #pharma #biotech
2024 Outlook for Pharma Mergers and Acquisitions
To view or add a comment, sign in
-
We are pleased to announce the release of the May 2024 edition of our Mergers and Acquisitions (M&A) report for the U.S. This report is an all-inclusive guide that provides details on the transactions carried out by American companies in May. May saw a significant shift in the mergers and acquisitions market in the U.S. A total of 1,144 transactions were announced within the country, a 2.0% increase compared to the same period last year. However, 145 transactions were carried out abroad, indicating an 11.6% decrease from the previous year. The report features notable companies such as Biogen, HI-Bio, AGS, and Mariana Oncology, showing the market's continued potential. If you want to receive this exclusive monthly report or any of our industry reports, kindly subscribe at https://lnkd.in/gExMnuBz. Stay ahead of the competition with our detailed analysis and insights. #MergersAndAcquisitions #BusinessReports #MarketTrends #USMarket #FinanceInsights #IndustryAnalysis #SealeAndAssociates #FinancialReports #CorporateTransactions #USCompanies
To view or add a comment, sign in
2,084 followers
Senior Director of Business Development, ex-formulator), LION over 14,000+ connections
2moGreat congratulations